{"id":70711,"date":"2026-05-12T09:38:54","date_gmt":"2026-05-12T09:38:54","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70711"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"dsip","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/dsip\/","title":{"rendered":"DSIP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 o DSIP?<\/h3>\n<p style=\"margin: 0;\"><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide first isolated from rabbit cerebral venous blood during electrical stimulation of thalamic sleep-promoting regions in 1977. In published studies it modulates sleep architecture \u2014 specifically slow-wave (delta) sleep \u2014 alongside documented effects on stress reactivity, withdrawal syndromes, and nociception. Supplied in 5\u00a0mg to 15\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">62568-57-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">848.81 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE, 9 amino\u00e1cidos; terminais lineares, n\u00e3o modificados)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (branco a branco sujo)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de utiliza\u00e7\u00e3o mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 o DSIP?<\/h2>\n<p><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid linear neuropeptide first isolated by Schoenenberger and Monnier at the University of Basel in 1977. The peptide was identified by dialysing cerebral venous blood from rabbits during electrical stimulation of the intralaminar thalamus \u2014 a region known to drive delta-wave (slow-wave) sleep in the cortex \u2014 and concentrating the bioactive fraction. DSIP was named for the dominant electroencephalographic signature it produced when administered to recipient animals: increased proportion of delta-wave activity during sleep. The well-characterised sequence is WAGGDASGE, molecular weight 848.81\u00a0Da, empirical formula C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub>. O DSIP \u00e9 estruturalmente incomum entre os pequenos pept\u00eddeos ativos no SNC \u2014 \u00e9 linear, n\u00e3o modificado em ambos os terminais e n\u00e3o cont\u00e9m res\u00edduos de prolina ou ciste\u00edna. O pept\u00eddeo \u00e9 fornecido como um p\u00f3 liofilizado de alta pureza para reconstitui\u00e7\u00e3o com \u00e1gua bacteriost\u00e1tica. O DSIP n\u00e3o \u00e9 <strong>aprovado<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For related circadian and sleep-axis peptide studies, see our <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> p\u00e1ginas de produtos. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Arquitetura do Sono, Reatividade ao Stress e Neuroprote\u00e7\u00e3o<\/h2>\n<p>What makes DSIP unusual among peptides is the breadth of effects documented for such a small, linear peptide without a clearly identified primary receptor. Published studies has mapped its activity across <strong>tr\u00eas dom\u00ednios sobrepostos<\/strong>, cada um contribuindo para o fen\u00f3tipo observado:<\/p>\n<ul>\n<li><strong>Modula\u00e7\u00e3o da arquitetura do sono \u2014 sono de ondas delta (sono de ondas lentas)<\/strong> \u2014 DSIP increases the proportion of slow-wave (stage 3\u20134 \/ N3) sleep on quantitative EEG measurements in rodent, rabbit, and human studies without proportionally reducing REM sleep. The effect is most pronounced when DSIP is administered to subjects with fragmented or shortened sleep, suggesting the peptide acts as a homeostatic sleep-pressure modulator rather than a primary sedative. Importantly, DSIP does not directly increase total sleep time in non-sleep-deprived subjects \u2014 it reorganises sleep architecture toward higher SWS proportion.<\/li>\n<li><strong>Modula\u00e7\u00e3o do eixo HPA e da reatividade ao stress<\/strong> \u2014 V\u00e1rios estudos publicados documentam a atenua\u00e7\u00e3o da liberta\u00e7\u00e3o de cortisol e ACTH induzida pelo stress em modelos de stress por conten\u00e7\u00e3o em roedores, juntamente com a redu\u00e7\u00e3o da sinaliza\u00e7\u00e3o da hormona libertadora de corticotropina (CRH) no hipot\u00e1lamo. O efeito de prote\u00e7\u00e3o contra o stress opera numa escala temporal mais longa do que os sedativos benzodiazep\u00ednicos e n\u00e3o produz seda\u00e7\u00e3o comportamental aguda, sugerindo uma modula\u00e7\u00e3o do t\u00f3nus do eixo HPA em vez de uma ansiolise aguda.<\/li>\n<li><strong>Anti-nocicep\u00e7\u00e3o, neuroprote\u00e7\u00e3o e anti-abstin\u00eancia<\/strong> \u2014 DSIP shows analgesic effects in rodent thermal and chemical-nociception models, including opioid-naive subjects (suggesting non-opioid mechanism). Russian and Eastern European has documented attenuation of opioid and alcohol withdrawal syndromes in preclinical models. Neuroprotective effects against oxidative stress, ischaemia, and excitotoxicity have been reported but remain mechanistically less well characterised than the sleep architecture work.<\/li>\n<\/ul>\n<p>The receptor target for DSIP has not been definitively identified, which is unusual for a peptide with this much published behavioural data. Proposed mechanisms include GABA-A modulation, opioid-system crosstalk, and direct interaction with hypothalamic CRH neurons. The lack of an identified primary receptor combined with multiple documented effects suggests DSIP may act as a multimodal neuromodulator rather than a classical receptor agonist \u2014 a hypothesis that remains an active studies question in published peptide pharmacology. <\/p>\n<h2>Published Evidence<\/h2>\n<p>DSIP is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Sleep architecture and EEG studies<\/strong> \u2014 quantitative EEG spectral analysis, slow-wave sleep proportion, sleep fragmentation in rodent and human studies (Schoenenberger &amp; Monnier, PNAS 1977; Kovalzon &amp; Strekalova, Sleep Med Rev 2006)<\/li>\n<li><strong>Stress reactivity and HPA-axis studies<\/strong> \u2014 din\u00e2mica do cortisol e ACTH, express\u00e3o de CRH, modelos de stress por conten\u00e7\u00e3o e stress cr\u00f3nico ligeiro em roedores<\/li>\n<li><strong>Withdrawal syndrome studies<\/strong> \u2014 gravidade da abstin\u00eancia de opi\u00f3ides, abstin\u00eancia de \u00e1lcool, desmame de benzodiazepinas; literatura publicada predominantemente russa e do Leste Europeu<\/li>\n<li><strong>Nociception and chronic pain studies<\/strong> \u2014 modelos de pux\u00e3o da cauda, placa quente, formalina e les\u00e3o por constri\u00e7\u00e3o cr\u00f3nica em roedores; caracteriza\u00e7\u00e3o de mecanismos n\u00e3o opi\u00f3ides<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 marcadores de stresse oxidativo, les\u00e3o de isquemia-reperfus\u00e3o, modelos de excitotoxicidade<\/li>\n<li><strong>Circadian biology studies<\/strong> \u2014 arrastamento, resposta de mudan\u00e7a de fase, modula\u00e7\u00e3o do ritmo de melatonina e temperatura central<\/li>\n<li><strong>Comparative sleep-axis peptide studies<\/strong> \u2014 compara\u00e7\u00e3o com <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> (tetrapept\u00eddeo pineal) para efeitos circadianos e com <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> para efeitos de prote\u00e7\u00e3o contra o stresse sem seda\u00e7\u00e3o.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre onde o DSIP se enquadra no panorama dos pequenos p\u00e9ptidos ativos no SNC, consulte <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> (AEDG pineal tetrapeptide, circadian-axis studies), <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> (heptapept\u00eddeo ansiol\u00edtico), e <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> (heptapept\u00eddeo nootr\u00f3pico). Explore a completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>MedsBase stocks DSIP in three lyophilized vial sizes covering pilot dosing through extended protocols. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, single-EEG-session studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, multi-week sleep-architecture studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>15\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos de ciclo prolongado, menor custo por mg, estudos com m\u00faltiplas coortes<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols or run extended studies from a single vial. <\/p>\n<h2>Como Comparar \u2014 DSIP vs Epitalon<\/h2>\n<p>DSIP e <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> are the two most-cited small peptides involved in sleep, circadian, and rest-state studies. They share several studies-relevant features \u2014 both are short, linear, unmodified peptides without identified primary receptors, and both produce phenotypic effects that outlast plasma clearance \u2014 but their primary signals are distinct: DSIP modulates sleep architecture directly via SWS proportion; Epitalon acts on the pineal-melatonin axis and circadian gene expression. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">DSIP<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 amino\u00e1cidos (linear)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 amino\u00e1cidos (tetrapept\u00eddeo)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">WAGGDASGE<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">AEDG (Ala-Glu-Asp-Gly)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Propor\u00e7\u00e3o de sono de ondas lentas (delta EEG)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Eixo pineal-melatonina, telomerase, express\u00e3o g\u00e9nica circadiana<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Recetor identificado<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum (neuromodulador multimodal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum (regula\u00e7\u00e3o g\u00e9nica, intracelular)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500\u00a0mcg, 1 vez por dia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310\u00a0mg, 1 vez por dia em ciclos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>In\u00edcio do efeito<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Na mesma sess\u00e3o (mensur\u00e1vel por EEG)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00e1rias semanas (escala temporal de express\u00e3o g\u00e9nica)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilhamento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Co-administered with Epitalon in circadian-sleep stack studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Co-administrado com DSIP para efeitos combinados de sono+ritmo circadiano<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For sleep-architecture studies, DSIP is the canonical first choice because it produces measurable EEG-level effects on slow-wave sleep proportion within a single sleep session. For circadian-rhythm and gene-regulatory studies, Epitalon is preferred because the effect timescale matches the underlying biology (gene expression changes over days to weeks). The two are frequently co-administered when both axes are part of the studies question. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138\u00a0\u00b0C na embalagem original para estoque de trabalho a curto prazo. Para armazenamento a longo prazo sem abertura, congele a \u221220\u00a0\u00b0C. O DSIP liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220\u00a0\u00b0C por at\u00e9 36 meses. Evite ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3 liofilizado. O DSIP \u00e9 higrosc\u00f3pico \u2014 feche os frascos imediatamente ap\u00f3s a abertura e armazene-os num recipiente dessecado, se dispon\u00edvel. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose. Swirl gently \u2014 do <strong>n\u00e3o<\/strong> agite vigorosamente \u2014 e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve ser l\u00edmpida e incolor. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138\u00a0\u00b0C e utilize dentro de 30 dias para estabilidade \u00f3tima. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is DSIP used for in studies?<\/h3>\n<p>DSIP is used in studies investigating sleep architecture (particularly slow-wave sleep proportion), HPA-axis and stress reactivity, opioid and alcohol withdrawal syndromes, non-opioid analgesia, neuroprotection, and circadian biology. It is the most-cited sleep-axis peptide that does not act primarily as a sedative \u2014 effects manifest as reorganisation of sleep architecture rather than increased total sleep time. The pharmaceutical-grade DSIP sold here is <strong>n\u00e3o<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>Como \u00e9 que o DSIP difere do Epitalon?<\/h3>\n<p>Both are small unmodified peptides without identified primary receptors that influence rest-state biology, but their primary signals differ. DSIP modulates sleep architecture at the EEG level \u2014 specifically increasing slow-wave sleep proportion within a single sleep session. Epitalon acts on the pineal-melatonin axis and circadian gene expression on a gene-expression timescale of days to weeks. The two are mechanistically complementary and frequently co-administered in studies investigating combined sleep and circadian endpoints. <\/p>\n<h3>What is the typical DSIP dose?<\/h3>\n<p>Protocolos pr\u00e9-cl\u00ednicos publicados utilizam tipicamente 100\u2013500\u00a0mcg por administra\u00e7\u00e3o em modelos de roedores, administrados por via subcut\u00e2nea ou intraperitoneal uma vez por dia durante ciclos de 7\u201328 dias. Um frasco de 5\u00a0mg reconstitu\u00eddo com 2,0\u00a0mL de \u00e1gua bacteriost\u00e1tica produz 2,5\u00a0mg\/mL \u2014 0,04\u00a0mL equivale a 100\u00a0mcg. <\/p>\n<h3>O DSIP \u00e9 aprovado pela FDA?<\/h3>\n<p>No. DSIP is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h3>Como deve ser armazenado o DSIP?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138\u00a0\u00b0C para stock de trabalho a curto prazo, ou \u221220\u00a0\u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. O DSIP \u00e9 higrosc\u00f3pico \u2014 feche os frascos imediatamente ap\u00f3s a abertura. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138\u00a0\u00b0C, utilizar no prazo de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o e descongela\u00e7\u00e3o degradam o p\u00e9ptido. Proteja sempre da luz direta. <\/p>\n<h3>Como reconstituir o DSIP?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e aguarde 2 a 5 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agite o frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 clara e incolor. Para um frasco de 5\u00a0mg + 2,0\u00a0mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 2,5\u00a0mg\/mL. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>MedsBase carries DSIP in 5\u00a0mg, 10\u00a0mg, and 15\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Does DSIP cause sedation in study models?<\/h3>\n<p>No \u2014 this is one of the most-cited findings in DSIP studies. Unlike benzodiazepines or other classical sedatives, DSIP does not produce acute behavioural sedation, motor coordination loss, or impaired alertness. Instead it modulates sleep architecture toward a higher proportion of slow-wave sleep when the subject does sleep, without increasing total sleep time in non-sleep-deprived subjects. This distinct profile is one of the reasons DSIP has remained a compound rather than a clinical sedative. <\/p>\n<h3>Can DSIP and Epitalon be stacked in studies?<\/h3>\n<p>Yes. DSIP and Epitalon act on different timescales and biological compartments (acute EEG-level sleep architecture vs gene-expression-level circadian regulation), so co-administration is not pharmacologically redundant. Study protocols studying combined sleep-quality and circadian-rhythm endpoints frequently use both peptides. <\/p>\n<h3>Does DSIP cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation. Long-term human safety data is limited because the peptide has not undergone modern Western regulatory review. The small size and lack of identified primary receptor are consistent with the clean tolerability profile. <\/p>\n<h3>Qual \u00e9 a meia-vida do DSIP?<\/h3>\n<p>In preclinical studies, DSIP has a plasma half-life of approximately 7\u201315 minutes following intravenous or subcutaneous administration. The short plasma half-life is offset by the peptide&#8217;s ability to cross the blood-brain barrier and produce effects on sleep architecture and gene expression that persist well beyond plasma clearance. <\/p>\n<h3>Por que foi o DSIP originalmente isolado?<\/h3>\n<p>O DSIP foi identificado em 1977 por Schoenenberger e Monnier na Universidade de Basileia atrav\u00e9s da di\u00e1lise do sangue venoso cerebral de coelhos durante a estimula\u00e7\u00e3o el\u00e9trica do t\u00e1lamo intralaminar \u2014 uma regi\u00e3o do c\u00e9rebro conhecida por induzir o sono de ondas delta (sono de ondas lentas). Concentraram a fra\u00e7\u00e3o bioativa e caracterizaram o p\u00e9ptido que produzia o efeito mais forte no EEG do sono quando transferido para animais recetores. O p\u00e9ptido foi nomeado pela sua assinatura eletroencefalogr\u00e1fica dominante: aumento da atividade de ondas delta durante o sono. <\/p>\n<h3>How long does DSIP take to show effects in preclinical studies?<\/h3>\n<p>Os efeitos agudos na arquitetura do sono e na propor\u00e7\u00e3o de ondas delta no EEG s\u00e3o detet\u00e1veis na primeira sess\u00e3o de sono ap\u00f3s a administra\u00e7\u00e3o. Os efeitos no eixo HPA e na reatividade ao stress acumulam-se ao longo de 7 a 14 dias de dosagem regular. Os efeitos anti-abstin\u00eancia em modelos de abstin\u00eancia de opi\u00e1ceos e \u00e1lcool s\u00e3o normalmente medidos em per\u00edodos de abstin\u00eancia de 3 a 7 dias. <\/p>\n<h3>Posso encomendar DSIP para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia DSIP para todo o mundo a partir da nossa rede dedicada de envio de pept\u00eddeos. As encomendas exclusivas de pept\u00eddeos qualificam-se para o nosso servi\u00e7o de envio aut\u00f3nomo de pept\u00eddeos. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura, com rastreio completo e est\u00e3o cobertas pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Garantia de Reenvio<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Sleep, Circadian, and CNS Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 pineal-melatonin axis and circadian gene-expression studies<\/li>\n<li><a href=\"\/pt-pt\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/pt-pt\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Heptapept\u00eddeo nootr\u00f3pico desenvolvido na R\u00fassia \u2014 modula\u00e7\u00e3o melanocortina e dopamin\u00e9rgica<\/li>\n<li><a href=\"\/pt-pt\/oxytocin-acetate\/\"><strong>Acetato de Oxitocina<\/strong><\/a> \u2014 9-aa cyclic nonapeptide \u2014 social-bonding and affiliative behavioural support<\/li>\n<li><a href=\"\/pt-pt\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore sleep, circadian, and CNS peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Explore a gama completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, com compostos relacionados incluindo <a href=\"https:\/\/medsbase.com\/pt-pt\/epitalon\/\">Epitalon<\/a> for circadian gene-expression studies, <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> for anxiolytic stress-axis studies, and <a href=\"https:\/\/medsbase.com\/pt-pt\/oxytocin-acetate\/\">Acetato de Oxitocina<\/a> for social-bonding behavioural support.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Pept\u00eddeo Indutor de Sono Delta (descoberto em 1977)<br \/>\n\u2705 Modula a arquitetura do sono de ondas lentas<br \/>\n\u2705 HPA-axis stress reactivity<br \/>\n\u2705 Analgesia anti-abstin\u00eancia e n\u00e3o opioide<br \/>\n\u2705 Atravessa a barreira hematoencef\u00e1lica<\/p>\n<p><strong>DSIP<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70946,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6275,5441],"class_list":["post-70711","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-dsip","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/70711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=70711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70946"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=70711"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=70711"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=70711"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=70711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}